Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  1995-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/AJRCCM.152.5.7582321PMID 7697274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survey of fatalities from skin testing and immunotherapy 1985-1989.

  1993cited by this paper
• Immediate adverse reactions to immunotherapy in allergy

  1992cited by this paper
• Publication bias in clinical research.

  1991cited by this paper
• Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract.

  1990cited by this paper
• Childhood asthma: application of the international view of management in Australia and New Zealand.

  1990cited by this paper
• Who will benefit from hyposensitization?

  1990cited by this paper
• Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma.

  1989cited by this paper
• Immunotherapy with dog and cat extracts in children

  1989cited by this paper
• Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy.

  1988cited by this paper
• The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.

  1988cited by this paper
• Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen

  1988cited by this paper
• The role of immunotherapy in cockroach asthma.

  1988cited by this paper
• Immunotherapy for cat asthma.

  1988cited by this paper
• Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma.

  1986cited by this paper
• Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy.

  1986cited by this paper
• A Double‐Blind, Multicenter Immunotherapy Trial in Children, Using a Purified and Standardized Cladosporium herbarum Preparation I. Clinical Results

  1986cited by this paper
• Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment.

  1985cited by this paper
• Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy.

  1985cited by this paper
• Immunotherapy in allergy to dog: a double-blind clinical study.

  1984cited by this paper
• A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects

  1984cited by this paper
• Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses.

  1984cited by this paper
• Clinical and immunologic evaluation of tyrosine-adsorbed Dermatophagoides pteronyssinus extract: a double-blind placebo-controlled trial.

  1984cited by this paper
• Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis.

  1984cited by this paper
• Failure of hyposensitisation in treatment of children with grass-pollen asthma.

  1982cited by this paper
• Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma.

  1978cited by this paper
• House dust mite hyposensitization.

  1978cited by this paper
• Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine.

  1978cited by this paper
• The role of ragweed pollen in autumnal asthma.

  1977cited by this paper
• Hyposensitisation with house dust mite vaccine in bronchial asthma.

  1976cited by this paper
• Hyposensitization with Dermatophagoides pteronyssinus Antigen: Trial in Asthma Induced by House Dust

  1971cited by this paper
• Hyposensitisation in mite asthma.

  1971cited by this paper
• Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component.

  1954cited by this paper
• Summer Hay-fever and Asthma Treated with Antihistaminic Drugs

  1953cited by this paper

• Real-world evidence of allergen immunotherapy

  2024cites this paper
• Allergen Immunotherapy for the Prevention and Treatment of Asthma

  2024cites this paper
• Omalizumab with allergen immunotherapy in respiratory & food allergy.

  2024cites this paper
• Allergen immunotherapy

  2024cites this paper
• Exosomes in asthma: Underappreciated contributors to the pathogenesis and novel therapeutic tools

  2024cites this paper
• Which patients with asthma are most likely to benefit from allergen immunotherapy?

  2022cites this paper
• Efficacy and safety of subcutaneous immunotherapy with a mixture of glutaraldehyde-modified extracts of Dermatophagoides pteronyssinus, Dermatophagoides farinae, and Blomia tropicalis

  2022cites this paper
• Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives

  2021cites this paper
• Medications Used in Asthma Management

  2021cites this paper
• Clinical evaluation of rush immunotherapy using house dust mite allergen in Japanese asthmatics

  2021cites this paper
• Role of Allergen Immunotherapy in Asthma Treatment and Asthma Development

  2020cites this paper
• Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.

  2020cites this paper
• Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop.

  2019cites this paper
• Immunotherapy for Allergic Rhinitis

  2019cites this paper
• GEMA (Spanish Guideline on the Management of Asthma)

  2019cites this paper
• GEMA (Guía española del manejo del asma)

  2018cites this paper
• Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma

  2018cites this paper
• Effects of Exercise Training on Pulmonary Function in Adults With Chronic Lung Disease: A Meta-Analysis of Randomized Controlled Trials.

  2018cites this paper
• Causes and Management of Asthma

  2018cites this paper
• Allergen-specific immunotherapy

  2018cites this paper
• Early Intervention is Important to Prevent Sensitization to New Allergens

  2018cites this paper
• [THE OFFICIAL MANUAL BOOK ON ALLERGEN-IMMUNOTHERAPY IN HOUSE-DUST-MITE ALLERGY].

  2018cites this paper
• Efficacy of House Dust Mite Sublingual Immunotherapy in Adults with Allergic Asthma.

  2017cites this paper
• The effect of allergen immunotherapy in the onset of new sensitizations: a meta‐analysis

  2017cites this paper
• Perceived efficacy and satisfaction of patients with subcutaneous hypoallergenic high-dose house dust mite extract a

  2017cites this paper
• Topical ocular treatment with monoclonal antibody Fab fragments targeting Japanese cedar pollen Cry j 1 inhibits Japanese cedar pollen‐induced allergic conjunctivitis in mice

  2017cites this paper
• Perceived efficacy and satisfaction of patients with subcutaneous hypoallergenic high-dose house dust mite extract.

  2017cites this paper
• Allergen immunotherapy: exploring areas for further inquiry

  2017cites this paper
• Gardening Intervention as a Low- to Moderate-Intensity Physical Activity for Improving Blood Lipid Profiles, Blood Pressure, Inflammation, and Oxidative Stress in Women over the Age of 70: A Pilot Study

  2017cites this paper
• Clinical and immunological effect of subcutaneous immunotherapy in allergic asthma

  2017cites this paper
• Safety of immunotherapy with glutaraldehyde modified allergen extracts in children and adults.

  2017cites this paper
• The united airways concept: from bench to bedside.

  2016cites this paper
• [Allergen immunotherapy: Mechanisms of action, and therapeutic and socioeconomic impact Consensus of the Asociación Colombiana de Alergia, Asma e Imunología].

  2016cites this paper
• Satisfaction and perceived effectiveness in patients on subcutaneous immunotherapy with a high-dose hypoallergenic pollen extract.

  2016cites this paper
• MESA REDONDA. CONTROVERSIAS EN EL ASMA INFANTIL. ¿CUÁLES SON LAS EVIDENCIAS? Inmunoterapia en el asma. ¿Tiene algún papel?

  2016cites this paper
• MESA REDONDA. CONTROVERSIAS EN EL ASMA INFANTIL. ¿C UÁLES SON LAS EVIDENCIAS?

  2016cites this paper
• Therapeutic interventions in severe asthma

  2016cites this paper
• Specific immunotherapy for rhinitis and asthma with a subcutaneous hypoallergenic high-dose house dust mite extract: results of a 9-month therapy.

  2016cites this paper
• New Horizons in Allergen Immunotherapy.

  2016cites this paper
• MESA REDONDA: CONSENSO SENP-SEICAP (Coordinador: L. García-Marcos Álvarez) (Moderadores: J. Garde Garde y F.J. Pérez Frías) Consenso de asma, neumología y alergia pediátrica (Borrador)

  2016cites this paper
• Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen‐induced allergic rhinitis

  2016cites this paper
• Asthma : Environmental Factors are Major Triggers in Children-A Teaching Hospital Experience

  2016cites this paper
• The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook

  2015cites this paper
• Inmunoterapia con alérgenos, ¿cuándo y por qué?

  2015cites this paper
• Updating the role played by immunotherapy for allergic rhinitis: meta‐analysis

  2015cites this paper
• Phase I study of subcutaneous allergen immunotherapy with Dermatophagoides pteronyssinus in patients with allergic rhinoconjunctivitis with or without asthma.

  2015cites this paper
• Role of immunotherapy in the treatment of allergic asthma.

  2014cites this paper
• Subcutaneous and sublingual immunotherapy: Where do we stand?

  2014cites this paper
• Patients on subcutaneous allergen immunotherapy are at risk of intramuscular injections

  2014cites this paper
• Allergen-specific regulation of allergic rhinitis in mice by intranasal exposure to IgG1 monoclonal antibody Fab fragments against pathogenic allergen.

  2014cites this paper
• Intratracheal exposure to Fab fragments of an allergen‐specific monoclonal antibody regulates asthmatic responses in mice

  2014cites this paper
• Respiratory Allergies: A General Overview of Remedies, Delivery Systems, and the Need to Progress

  2014cites this paper
• Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta‐analysis of randomized, double‐blind and placebo‐controlled trials

  2014cites this paper
• Medical management of allergic fungal rhinosinusitis following endoscopic sinus surgery: an evidence‐based review and recommendations

  2014cites this paper
• Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.

  2013cites this paper
• Eficacia de la inmunoterapia subcutánea con extractos de ácaros en adultos asmáticos

  2013cites this paper
• Journal of Allergy and clinical immunology

  2013cites this paper
• The evolution of allergen immunotherapy from empirical desensitization to immunological treatment.

  2013cites this paper
• Changes in IL-10 and specific antibodies associated to successful Dermatophagoides pteronyssinus immunotherapy in children during the first year of treatment.

  2013cites this paper
• Safety of cluster specific immunotherapy with a modified high-dose house dust mite extract.

  2013cites this paper
• Allergen immunotherapy for allergic rhinitis.

  2013cites this paper
• Effectiveness of subcutaneous immunotherapy with mite extracts in asthmatic adults

  2013cites this paper
• Allergy, living and learning: diagnosis and treatment of allergic respiratory diseases in Europe.

  2012cites this paper
• Hypoallergenic high-dose immunotherapy proves effective and safe in a multicentre surveillance study

  2012cites this paper
• Immunotherapy in Allergic Skin Disease

  2012cites this paper
• Factors affecting time required to reach maintenance dose during subcutaneous immunotherapy

  2012cites this paper
• Severe asthma: from characteristics to phenotypes to endotypes

  2012cites this paper
• Practice Patterns of Allergen Immunotherapy in Korea: Where Are We?

  2012cites this paper
• Allergen immunotherapy: how to balance the different views from pulmonologists and allergists?

  2012cites this paper
• Does Allergen Immunotherapy Alter the Natural Course of Allergic Disorders?

  2012cites this paper
• Interference in foraging behaviour of European and American house dust mites Dermatophagoides pteronyssinus and Dermatophagoides farinae (Acari: Pyroglyphidae) by catmint, Nepeta cataria (Lamiaceae)

  2012cites this paper
• Comparing subcutaneous and sublingual ımmunotherapy: what do we know?

  2012cites this paper
• Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.

  2012cites this paper
• IRRATIONAL ASTHMA THERAPY OF A CHILD; A CASE REPORT

  2012cites this paper
• Drug Treatment of Asthma in the 1990s

  2012cites this paper
• Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy

  2012cites this paper
• Skin prick test and immunotherapy in children with allergic eye disease

  2012cites this paper
• Economic Evaluation of Specific Immunotherapy Versus Symptomatic Treatment of Allergic Rhinitis in Germany

  2012cites this paper
• Allergen immunotherapy: 100 years, but it does not look like.

  2012cites this paper
• Current and Emerging Pharmacotherapies in Children with Moderate to Severe Chronic Asthma

  2011cites this paper
• Immunotherapy: The meta-analyses. What have we Learned?

  2011cites this paper
• Pathogenesis of airway inflammation in bronchial asthma.

  2011cites this paper
• Some highlights of the first century of immunotherapy.

  2011cites this paper
• Specific immunotherapy in asthma: efficacy and safety

  2011cites this paper
• One century of allergen-specific immunotherapy for respiratory allergy.

  2011cites this paper
• Immunotherapy - Vaccines for allergic diseases.

  2011cites this paper
• Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.

  2011cites this paper
• Indicaciones de la inmunoterapia en la edad pediátrica

  2011cites this paper
• Allergen immunotherapy in asthma: current evidence and future requirements.

  2011cites this paper
• Clinico‐immunological changes post‐immunotherapy with Periplaneta americana

  2011cites this paper
• Efficacy of immunotherapy for treatment of allergic asthma in children.

  2010cites this paper
• Cluster protocols in SCIT: enough evidence for practical use?

  2010cites this paper
• 1,25-dihydroxyvitamin D₃ pretreatment enhances the efficacy of allergen immunotherapy in a mouse allergic asthma model.

  2010cites this paper
• [ALERTA 2 guidelines. Latin America and Spain: recommendations for the prevention and treatment of asmatic exacerbations. Spanish Pulmonology and Thoracic Surgery Society (SEPAR). Asthma Department of the Latinamerican Thoracic Association (ALAT)].

  2010cites this paper
• CpG Oligodeoxynucleotides as TLR9 Agonists

  2010cites this paper
• Immunotherapy for Allergic Disease

  2010cites this paper
• Proteolytically Inactive Per a 10 Allergen of Periplaneta americana Modulates Th2 Response and Enhances IL-10 in Mouse Model

  2010cites this paper
• AMBIENTE Y ESTILO DE VIDA EN LA PREVENCIÓN DEL ASMA EN EL NIÑO

  2010cites this paper
• Guía ALERTA 2. América Latina y España: Recomendaciones para la prevención y el Tratamiento de la exacerbación Asmática

  2010cites this paper
• Allergen immunotherapy in asthma: current status and future perspectives.

  2010cites this paper